The Association Between Health Insurance and Opioid Misuse in Pregnancy
Author(s) -
Paula Trepman,
Melissa Villars,
YuTing Chang,
Zohn Rosen
Publication year - 2020
Publication title -
journal of scientific innovation in medicine
Language(s) - English
Resource type - Journals
ISSN - 2579-0153
DOI - 10.29024/jsim.46
Subject(s) - medicaid , medicine , pregnancy , odds ratio , odds , national survey of family growth , opioid , socioeconomic status , family medicine , private insurance , obstetrics , health care , demography , logistic regression , environmental health , population , family planning , genetics , receptor , sociology , research methodology , biology , economics , economic growth
We sought to evaluate the association between insurance type and non-medical opioid use in pregnant women in the United States. We conducted a study in women aged 12 to 49 years using the 2005–2014 National Survey on Drug Use and Health (NSDUH). Though multivariable regression, we specifically analyzed the difference in non-medical opioid use during pregnancy between women covered by Medicaid versus private insurance. A total of 244,353 reproductive-aged women were included. Of those women, 8,862 (3.6%) were pregnant at the time of survey and 79 (0.03%) reported non-medical opioid use in the past month. After controlling for socioeconomic factors, we found nonmedical opioid use was greater for pregnant women on Medicaid compared to private insurance in the second trimester (adjusted odds ratio, 6.5; p = .015), despite no significant difference in the first trimester (0.84; p = .656). This difference may suggest a discrepancy in access to care.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom